Does Dr. CHANDA BABINEAUX have financial conflicts of interest?

Dr. CHANDA BABINEAUX (MD) has received a total of $663 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $663 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. CHANDA BABINEAUX?

According to CMS Open Payments data, Dr. CHANDA BABINEAUX received funding from ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .) ($73), KOWA PHARMACEUTICALS AMERICA ($67), and LILLY USA ($63).

Does Dr. CHANDA BABINEAUX receive research grants or speaking fees?

Dr. CHANDA BABINEAUX has received $663 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. CHANDA BABINEAUX

MDReal-Time Hydrated

Specialty: Nurse Practitioner

Practice Location: OPELOUSAS, LA 70570

NPI Number: 1831960475

LIFETIME INDUSTRY VALUE

$663

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BABINEAUX is a verified Nurse Practitioner practitioner based in OPELOUSAS, LA.

Between 2021 and 2025, Dr. BABINEAUX had an overall industry promotional and research financial footprint of $663 as recorded in the federal CMS Open Payments database.

$663 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BABINEAUX's primary funding source is ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .), which accounts for $73 (representing 11% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ITI, . (D/B/A INTRA-CELLULAR THERAPIES, .)

Rank 1

$73

11%

KOWA PHARMACEUTICALS AMERICA

Rank 2

$67

10.1%

LILLY USA

Rank 3

$63

9.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.